flow cytometry

Are we ready for MRD-guided therapy in multiple myeloma?

Using single-cell multiomics to predict patients at risk for antigen escape after CAR-T therapy

The importance of MRD monitoring in AML

MRD-driven HSCT for ALL

The importance of genomic testing in CLL prognosis

Assessing MRD in hematologic malignancies

Reconstructing clonal evolution from dysplasia to AML

Diagnostic tools for AML

Methods to access the clinical efficacy of mogamulizumab

Integrated approaches to the diagnosis of MDS & MPNs

The evolution of MRD for myeloma

MRD: from clinical trials to clinical practice

Measuring MRD: methods and challenges

MRD-negativity as a surrogate for PFS and OS

The role of MRD in AML

Importance of MRD monitoring in ALL